## Abstract We evaluated the relationship between upper extremity (UE) and lower extremity (LE) motor impairments in Parkinson's disease (PD) to overall disability and quality of life (QoL) measures. A total of 639 patients who were diagnosed with idiopathic PD were administered the Unified Parkins
Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease
β Scribed by Bart Post; Dino Muslimovic; Nan van Geloven; Johannes D. Speelman; Ben Schmand; Rob J. de Haan; on behalf of the CARPA-study group
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 128 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objective:
To determine progression and prognostic factors of progression rate of motor impairment, disability, and quality of life (QoL) in patients with newly diagnosed Parkinson's disease.
Methods:
A group of 126 patients with newly diagnosed PD recruited from outpatient clinics participated in this 3βyear prospective cohort study. Motor impairment was rated with the Unified Parkinson Disease Rating Scale MotorβExamination. Disability was rated using the Schwab and England Activities of Daily Living Scale, the AMC Linear Disability Score. QoL was assessed with the Parkinson's Disease Quality of Life questionnaire. Linear mixed model analyses were conducted to identify determinants of progression rate of motor impairment, disability, and poor QoL.
Results:
Motor impairment progressed with 3 points per year. There was a slight progression of disability and QoL during 3 years of followβup. Female sex was a prognostic factor for slower progression of motor impairment and QoL. Older age at onset showed to prognosticate faster progression of disability and impaired QoL. Furthermore, independent of followβup time, older age at onset was associated with worse motor impairment; nondopaminergic reactive symptoms (Axial impairment) were associated with more disability and poorer QoL; comorbidity showed relation with disability and QoL but to a lesser extent; selfβreported mood symptoms were associated with poorer QoL; and disease duration correlated with motor impairment.
Conclusions:
Motor impairment, disability, and QoL of newly diagnosed Parkinson patients show progression in the first 3 years. Older age at onset predicts worse progression rate of disability and impaired QoL over time. Female sex predicts slower progression of motor impairment and less decline of QoL. Β© 2011 Movement Disorder Society
π SIMILAR VOLUMES
OBJECTIVE: To monitor comparative progression of clinical impairment over 4 years in patients with Parkinson's disease (PD) who present on levodopa at two different levels of Hoehn and Yahr (HY) stages, II and III. BACKGROUND: The rate of clinical impairment progression in patients with PD being tr
## Abstract The impact of dyskinesias and motor fluctuations on quality of life (QOL) at various stages in the course of Parkinson's disease (PD) is not well understood. In 301 subjects with early PD enrolled in a clinical trial (CALMβPD), we quantified the impact of motor complications on QOL and
## Abstract Although the Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to monitor disease progression and drug efficacy, no attempts have been made to evaluate its scientific and clinical quality. Poor clinical sensibility of items in the activities of daily living (ADL) section a
## Abstract We assessed the clinometric characteristics of rating scales used for the evaluation of motor impairment and disability of patients with Parkinson's disease (PD), conducting a systematic review of PD rating scales published from 1960 to the present. Thirty studies describing clinometric
## Abstract Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in firstβdegree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Id